18th September 2017
article written by
Cell Medica

Cell Medica announces the appointment of Luis Borges, PhD, as Chief Scientific Officer

Cell Medica Announces the appointment of Luis Borges, PhD, as Chief Scientific Officer to accelerate R&D for CAR and TCR programmes Luis will spearhead the Company’s global research group, including teams in London, Zurich and Houston. Luis brings extensive knowledge of cancer immunotherapy from twenty years of experience in the field, including senior positions at Five […]

Read Full Article
20th June 2017
article written by
Cell Medica

Cell Medica acquires WT1 cancer immunotherapy from Cell and Gene Therapy Catapult

Cell Medica acquires WT1 cancer immunotherapy from Cell and Gene Therapy Catapult Acquisition transfers rights for WT1-TCR cell therapy from CGT Catapult to Cell Medica Collaboration for development, scale-up and manufacturing also established London, 20 June 2017 – Cell Medica today announced the acquisition of Catapult Therapy TCR Limited, a subsidiary of Cell and Gene […]

Read Full Article
16th May 2017
article written by
Cell Medica

Jefferies 2017 Global Healthcare Conference

June 6-9, 2017 – New York, NY Gregg Sando will be presenting at 8:30AM on June 6 at the Jefferies 2017 Global Healthcare Conference The Jefferies 2017 Global Healthcare Conference will be taking place June 6-9 in New York City. http://www.jefferies.com/OurFirm/Conferences/325/318

Read Full Article
30th March 2017
article written by
Cell Medica

Cell Therapy Manufacturing & Gene Therapy Digital Week – A Closer Look at Orphan ATMP Development, Incentives and Similarity.

Cell Therapy Manufacturing & Gene Therapy Digital Week – A Closer Look  at Orphan ATMP Development, Incentives and Similarity. Clinical Development for Cell, Gene and Immunotherapies A Closer Look  at Orphan ATMP Development, Incentives and Similarity. Alex Bloom of Cell Medica presented at Cell Gene Digital Week. Watch the on-demand webinar here http://spr.ly/60108gWqn  With an […]

Read Full Article